capture-based targeted sequencing panel (Burning Rock Biotech Ltd)
90
Structured Review
Burning Rock Biotech Ltd
capture-based targeted sequencing panel
Capture Based Targeted Sequencing Panel, supplied by Burning Rock Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/capture+based+targeted+sequencing+panel/pmc09811622__Supplementary_Data-35-5-9
Average 90 stars, based on 1 article reviews
Capture Based Targeted Sequencing Panel, supplied by Burning Rock Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capture+sequence/capture+based+targeted+sequencing+panel/pmc09811622__Supplementary_Data-35-5-9
Average 90 stars, based on 1 article reviews
capture-based targeted sequencing panel - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Targeted Sequencing:Article Title: Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Article Snippet: DNA fragmentation was detected on an Agilent 2100 Bioanalyzer. .. The 60 matched tumor tissue samples were processed using a commercially available, capture- based targeted Article Title: BTK inhibitor combined with anti-PD-1 monoclonal antibody for the treatment of CD20-negative primary central nervous system lymphoma: A case report Article Snippet: .. DNA was profiled using a capture‐based targeted Article Title: Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next‐Generation Sequencing With Insufficient Tumor Samples Article Snippet: DNA fragmentation was detected on an Agilent 2100 Bioanalyzer. .. The 60 matched tumor tissue samples were processed using a commercially available, capture‐based targeted other:Article Title: Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib Article Snippet: DNA was profiled using a commercially available Isolation:Article Title: Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer. Article Snippet: a Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China b Graduate School, University of South China, Hengyang, Hunan, 421001, China c Department of Pharmacy, Hunan Cancer Hospital, Changsha, 410011, China d Center of New Drug Clinical Trials, Hunan Cancer Hospital, Changsha, 410011, China e Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China f Burning Rock Biotech, Guangzhou, 510300, China g Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, China h Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA Next-Generation Sequencing:Article Title: Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer. Article Snippet: a Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China b Graduate School, University of South China, Hengyang, Hunan, 421001, China c Department of Pharmacy, Hunan Cancer Hospital, Changsha, 410011, China d Center of New Drug Clinical Trials, Hunan Cancer Hospital, Changsha, 410011, China e Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China f Burning Rock Biotech, Guangzhou, 510300, China g Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, China h Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA Sequencing:Article Title: Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer. Article Snippet: a Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China b Graduate School, University of South China, Hengyang, Hunan, 421001, China c Department of Pharmacy, Hunan Cancer Hospital, Changsha, 410011, China d Center of New Drug Clinical Trials, Hunan Cancer Hospital, Changsha, 410011, China e Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China f Burning Rock Biotech, Guangzhou, 510300, China g Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, China h Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA Article Title: A computed tomography (CT)-derived radiomics approach for predicting primary co-mutations involving TP53 and epidermal growth factor receptor ( EGFR ) in patients with advanced lung adenocarcinomas (LUAD) Article Snippet: .. Genomic profiling was performed by using a commercially available capture based targeted |
